Persistent donor-specific alloreactivity may portend delayed liver rejection during drug minimization in children.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Frontiers in Bioscience

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2741/2090PMID 17127326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Back to the Future

  2005cited by this paper
• Enhanced Donor‐Specific Alloreactivity Occurs Independently of Immunosuppression in Children with Early Liver Rejection

  2005cited by this paper
• Enzyme Linked Immunosorbent Spot (ELISPOT) Assay for Interferon‐Gamma Independently Predicts Renal Function in Kidney Transplant Recipients

  2003cited by this paper
• Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus1

  2002cited by this paper
• Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors

  2002cited by this paper
• Back to the future

  2001cited by this paper
• Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients.

  1998cited by this paper

• Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children

  2017cites this paper
• Profile of the Pleximmune blood test for transplant rejection risk prediction

  2016cites this paper
• Antithymocyte Globulin Facilitates Alloreactive T-cell Apoptosis by Means of Caspase-3: Potential Implications for Monitoring Rejection-Free Outcomes

  2015cites this paper
• Immune monitoring post liver transplant.

  2014cites this paper
• Allospecific CD154 + T‐cytotoxic memory cells as potential surrogate for rejection risk in pediatric intestine transplantation

  2012cites this paper
• Cellular alloresponses for rejection-risk assessment after pediatric transplantation

  2011cites this paper
• Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients.

  2011cites this paper
• Proliferative Alloresponse of T Cytotoxic Cells Identifies Rejection-Prone Children With Small Bowel Transplantation

  2010cites this paper
• Phenotypic and Transcriptional Biomarkers In Organ Transplantation

  2010cites this paper
• Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.

  2009cites this paper
• Proliferative alloresponse of T‐cytotoxic cells identifies rejection‐prone children with steroid‐free liver transplantation

  2009cites this paper
• Lymphocyte subset reconstitution in pediatric liver recipients induced with steroid‐free rabbit anti‐human thymocyte globulin

  2008cites this paper
• Allospecific CD154+ T Cells Associate with Rejection Risk After Pediatric Liver Transplantation

  2008cites this paper
• ImmuKnow: A new parameter in immune monitoring of pediatric liver transplantation recipients

  2008cites this paper
• Functional Assessment of Immunosuppression: Monitoring Posttransplant Alloreactivity with Flow Cytometric Mixed Lymphocyte Cocultures

  2008cites this paper
• Improving Long‐Term Outcomes After Liver Transplantation in Children

  2008cites this paper